B3.066 - CBCL Thrombocytopenia Flashcards
What is TTP
pentad characterization 1. fever 2. thrombocytopenia 3. transient neuro deficits 4. renal failure 5. microangiopathic hemolytic anemia
what causes TTP
deficiency in ADAMTS13, which cleaves/degrades very high molecular weight vWF, leading to more clotting
who is at higher risk for TTP
african american women and pregnant women
what genetic tests can you do fro TTP
mutations in ADAMTS13
common causes of TTP
ADAMTS13 mutations (Upshaw-Schulman syndrome) HIV Autoimmune disorders preglancy some drugs
symptoms of TTP
malaise bleeding altered mental status low grade fever petechiae pallor jaundice confusion seizures
tests for TTP
ADAMTS13 activity and circulating ADAMTS13 antibody negative coombs polychromasia elevated LDH elevated bilirubin bc of heme metabolism elevated BUN with kidney failure
differential for TTP
sepsis vasculitis
how do you differentiate sepsis from TTP
sepsis will have normal ADAMTS13 levels
how do you differentiate vasculitis from TTP
not usually associated with microthrombi or hemolytic anemia
how do you differentiate TTP from malignant hypertension
retinopathy grade III or IV seen in malignant HT not TTP
how do you differentiate TTP from Autoimmune hemolytic anemia
positive coombs test spherocytes rather than schistocytes on PBS, no MAHA
first line of treatment for TTP
plasma exchange
what type of plasma is given for TTP and what line of therapy is it and what do you have to be careful of
fresh frozen plasma 2nd line, careful not to overload patient so you have to give slowly
are antiplatelets helpful in TTP
no
is a platelet transfusion helpful in TTP?
no
what is aHUS
characterized by microangiopathic hemolytic anemia and thrombocytopenia, prominent in renal insufficiency
how does aHUS happen
associated with defects in complement factor H, membrane cofactor CD46 or factor I. Deficiency of complement regulatory proteins leads to activation of alternative complement system
what proteins are associated with activation of alternative complement system in aHUS
factor H factor I membrane cofactor protein thrombomodulin
what factors are associated with aberrant activation of alternative complement pathway
factor B Factor C3
secondary aHUS
initiated by coexisting disease or condition